DALLAS, June 12, 2018 — The American Heart Association—the world’s leading voluntary organization dedicated to building healthier lives, free of cardiovascular diseases and stroke—announced today research grants totaling more than $28 million to the scientific teams that will create a new research network focused on understanding the causes of atrial fibrillation (AFib).

A Boston-area cardiologist and an advocate against nuclear weapons met with North Korean diplomats ahead of the 2018 United States-North Korea Summit in Singapore, reports WFXT, the FOX affiliate in Boston.

A Cleveland-area cardiologist who is currently serving a 20-year prison sentence for healthcare fraud, money laundering and subjecting patients to unnecessary testing is asking a judge to overturn his case, reports Cleveland.com.

A new study published in PLOS Medicine suggests people prescribed a single-pill fixed-dose drug combination (FDC) to manage hypertension are more likely to be compliant with their medication and achieve better health outcomes than those taking separate pills.

Boston Scientific said Monday it won't comment on reports rival medical device manufacturer Stryker made a takeover bid. The news was first reported by The Wall Street Journal. Stryker also stated it does not comment on potential mergers or acquisitions.

The first coagulation monitoring device with built-in Bluetooth technology is expected to be commercially available this summer to warfarin patients in the United States, according to device-maker Roche Diagnostics.

Scientists are researching how to take stem cells from the patient’s blood to repair damage to the heart. A new therapy could reduce the need for operations, the U.K.’s Express newspaper reports, with researchers hoping the therapy could save lives while being cost effective. 

Anheuser-Busch InBev decided to pull funding from a long-term study of moderate alcohol intake and its effects on cardiovascular health after concerns were raised about the objectivity of the research.

A scientist at the American Society of Clinical Oncology (ASCO)’s annual meeting discussed how cardiac imaging and biomarker measurements could improve care for cancer survivors.

Stryker approached Boston Scientific with a takeover bid on Monday, June 11, according to the Wall Street Journal.